proliferator-activated receptor γ (PPARγ) is a well-known target for thiazolidinedione antidiabetic drugs. In this paper, we present the synthesis and biological evaluation of a series of dihydropyrano[2,3-c]pyrazole derivatives as a novel family of PPARγ partial agonists. Two analogues were found to display high affinity for PPARγ with potencies in the micro molar range. Both of these hits were selective
过氧化物酶体增殖物激活受体γ(
PPARγ)是
噻唑烷二
酮类抗糖尿病药物的众所周知的靶标。在本文中,我们介绍了一系列作为新的
PPARγ部分激动剂家族的二氢
吡喃并[2,3-c]
吡唑衍
生物的合成和
生物学评价。发现两个类似物对
PPARγ表现出高亲和力,且效力在微摩尔范围内。由于针对
PPARα,
PPARδ和RXRα进行测试时未检测到活性,因此这两种命中均对
PPARγ具有选择性。此外,开发了一种基于多种个体柔性比对的新颖建模方法,用于鉴定
PPARγ中的
配体结合相互作用。结合基于细胞的反式激活实验,